EPIZYME, INC. Operating Lease Cost
EPIZYME, INC. reported Operating Lease Cost of $1.69 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-08-09
- EPIZYME, INC. operating lease, cost for the quarter ending 2022-06-30 was $1.69M, a 11.49% increase year-over-year.
- EPIZYME, INC. operating lease, cost for the quarter ending 2022-03-31 was $1.69M, a 11.49% increase year-over-year.
- EPIZYME, INC. operating lease, cost for the quarter ending 2021-12-31 was $1.66M, a 10.84% increase year-over-year.
- EPIZYME, INC. operating lease, cost for the quarter ending 2021-09-30 was $1.60M, a 3.15% increase year-over-year.
- EPIZYME, INC. operating lease, cost for fiscal 2021 was $6.29M, a 2.21% increase from fiscal 2020.
- EPIZYME, INC. operating lease, cost for fiscal 2020 was $6.16M, a 63.22% increase from fiscal 2019.
- EPIZYME, INC. operating lease, cost for fiscal 2019 was $3.77M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | $1.69M 10-Q · filed 2022-08-09 | $3.38M 10-Q · filed 2022-08-09 | $5.04M derived: sum of 3 quarters · filed 2022-08-09 | $6.64M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $1.69M 10-Q · filed 2022-05-10 | $3.35M derived: sum of 2 quarters · filed 2022-05-10 | $4.95M derived: sum of 3 quarters · filed 2022-05-10 | $6.46M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.26M derived: sum of 2 quarters · filed 2022-03-01 | $4.78M derived: sum of 3 quarters · filed 2022-08-09 | $6.29M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-09 | $3.12M derived: sum of 2 quarters · filed 2022-08-09 | $4.63M 10-Q · filed 2021-11-09 | $6.13M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $1.51M 10-Q · filed 2022-08-09 | $3.03M 10-Q · filed 2022-08-09 | $4.53M derived: sum of 3 quarters · filed 2022-08-09 | $6.08M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.51M 10-Q · filed 2022-05-10 | $3.01M derived: sum of 2 quarters · filed 2022-05-10 | $4.56M derived: sum of 3 quarters · filed 2022-05-10 | $6.12M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.05M derived: sum of 2 quarters · filed 2022-03-01 | $4.60M derived: sum of 3 quarters · filed 2022-03-01 | $6.16M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.55M 10-Q · filed 2021-11-09 | $3.11M derived: sum of 2 quarters · filed 2021-11-09 | $4.66M 10-Q · filed 2021-11-09 | $5.76M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.55M 10-Q · filed 2021-08-09 | $3.10M 10-Q · filed 2021-08-09 | $4.21M derived: sum of 3 quarters · filed 2022-03-01 | $5.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.55M 10-Q · filed 2021-05-06 | $2.66M derived: sum of 2 quarters · filed 2022-03-01 | $3.54M derived: sum of 3 quarters · filed 2022-03-01 | $4.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.99M derived: sum of 2 quarters · filed 2022-03-01 | $2.88M derived: sum of 3 quarters · filed 2022-03-01 | $3.77M 10-K · filed 2022-03-01 |
| 2019-09-30 | $888.00K 10-Q · filed 2020-11-06 | $1.78M derived: sum of 2 quarters · filed 2020-11-06 | $2.67M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $889.00K 10-Q · filed 2020-08-04 | $1.78M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $888.00K 10-Q · filed 2020-05-04 |